Many hormone therapies still use estrogen derived from horses rather than hormones identical to those produced by the human body. Understanding the difference between synthetic and biomimetic hormone therapy may dramatically improve menopause treatment outcomes.
Menopause is often treated as something women simply have to endure. Hot flashes, brain fog, sleep disturbances, weight gain, and mood changes are commonly dismissed as unavoidable parts of aging.
But many women are surprised to learn that the hormone therapy they are prescribed may not actually match the hormones their bodies naturally produced.
In fact, some widely used estrogen medications are derived from horses, not humans.
Understanding the difference between synthetic hormone therapy and biomimetic hormone restoration can dramatically change how menopause symptoms are managed and how effectively treatment works.
Conventional hormone replacement therapy often relies on standardized medications designed for broad populations rather than individualized hormone balance.
One of the most well-known medications used in traditional therapy is Premarin. The name itself comes from pregnant mare’s urine, the source of the equine estrogens used in the drug.
While this medication has been used for decades and can relieve some symptoms, these estrogens are not molecularly identical to the hormones naturally produced by the human body.
That difference matters.
When hormones are not structurally identical to those your body previously produced, the way they interact with receptors and metabolic pathways may differ as well. For some women, this results in only partial symptom relief or unwanted side effects.
Many women continue experiencing symptoms such as:
Despite being on hormone therapy.
Biomimetic hormone therapy uses hormones that are molecularly identical to those produced by the body earlier in life.
Instead of equine estrogens, biomimetic therapy typically uses the three primary human estrogens:
Because these hormones match the body’s natural chemistry, they are recognized and processed more predictably.
Research has shown that transdermal estradiol, delivered through the skin rather than orally, may carry a lower risk of blood clots compared to older oral estrogen therapies.
This shift in delivery method is one of the reasons modern hormone therapy protocols differ significantly from the ones studied decades ago.
For women who still have a uterus, progesterone must be included alongside estrogen therapy to protect the uterine lining.
However, the form of progesterone used makes an important difference.
Many conventional therapies use synthetic progestins, such as medroxyprogesterone acetate. These synthetic compounds have been associated with increased breast cancer risk when combined with estrogen and may cause side effects such as mood swings and fatigue.
Natural progesterone, which is structurally identical to the hormone produced by the body, has demonstrated a more favorable safety profile in many clinical observations.
In addition to protecting the uterus, natural progesterone may also support:
Another important hormone often overlooked in women’s health is testosterone.
Although commonly associated with men, testosterone plays a crucial role in women’s physiology. Before menopause, women produce meaningful levels of testosterone that contribute to:
A 2019 global consensus statement confirmed that testosterone therapy can benefit postmenopausal women experiencing low sexual desire.
When carefully calibrated alongside estrogen and progesterone, testosterone can help restore overall hormonal balance rather than treating symptoms in isolation.
Hormone therapy should never be purely standardized.
Each woman’s hormonal profile, metabolism, symptoms, and health history are unique. A personalized hormone restoration plan evaluates these variables to determine the appropriate combination, dosage, and delivery method.
Instead of simply suppressing symptoms, the goal is to recreate the hormonal environment that supported health and vitality earlier in life.
This personalized approach often leads to better symptom control and improved quality of life.
If you are considering hormone therapy, there is one critical question that can shape your treatment outcome:
“Are you prescribing hormones that are identical to what my body naturally produced, and how will you personalize the dosage for me?”
This question helps ensure that treatment decisions focus on restoring balance rather than applying a standardized prescription that may not be optimal for your body.
Modern hormone therapy is evolving.
Rather than accepting menopause as a period of unavoidable decline, many clinicians now focus on restoring hormonal balance in ways that support long-term health, vitality, and well-being.
For many women, understanding the difference between synthetic hormone replacement and biomimetic hormone restoration is the first step toward reclaiming energy, clarity, and quality of life.
Mark Filosi, BSc Pharm, RPh, is a compounding pharmacist with over 30 years of experience specializing in BHRT and metabolic health. He is the president of Family Care Pharmacy in Plant City, FL and owner of Live and Learn Pharmacy. Mark is a Medisca compounding facilitator, PCAP ACHC surveyor, and has served as an SPCC judge for over a decade. He has been featured on the LDN Research Trust Radio Show discussing low-dose naltrexone therapy.
